Serum CCL27 predicts the response to Bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer

The prediction of the response to Bacillus Calmette-Guerin (BCG) can help identify non-muscle-invasive bladder cancer (NMIBC) patients that may be better served with alternative therapy. Several cytokine profiles present promising results, but they are difficult to use in clinical practice. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Wenlong, Wang, Bo, Yu, Hao, Lin, Jianxun, Xia, Kun, Hou, Weibin, Yang, Meihua, Chen, Junyu, Yang, Meng, Wang, Xiaofei, Huang, Jian, Lin, Tianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458591/
https://www.ncbi.nlm.nih.gov/pubmed/32923138
http://dx.doi.org/10.1080/2162402X.2020.1776060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458591/
https://www.ncbi.nlm.nih.gov/pubmed/32923138
http://dx.doi.org/10.1080/2162402X.2020.1776060

Ejemplares similares